Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588042 · ClinicalTrials.gov registry record · NA
Remote Myocardial Ischemic Preconditioning in Humans
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 156
- Enrollment target
NCT00588042: Completed NA study, sponsored by Mayo Clinic.
NCT00588042 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 156 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00588042, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
Study Summary
Ischemic preconditioning (IP) has been shown in animal studies to increase the myocardial tolerance to subsequent ischemia. Our primary hypothesis is that remote IP reduces myocardial ischemic injury during PCI.
Interventions
- DEVICE Blood pressure cuff
- DEVICE blood pressure cuff
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00588042
The ClinicalTrials.gov registry entry for NCT00588042 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood pressure cuff is the first listed.
NCT00588042 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00588042 about?
NCT00588042 is a clinical study titled "Remote Myocardial Ischemic Preconditioning in Humans". Ischemic preconditioning (IP) has been shown in animal studies to increase the myocardial tolerance to subsequent ischemia. Our primary hypothesis is that remote IP reduces myocardial ischemic injury during PCI.
What is the current status of trial NCT00588042?
This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2007-10. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00588042?
The interventions under investigation include: Blood pressure cuff (DEVICE), blood pressure cuff (DEVICE).
Who is sponsoring clinical trial NCT00588042?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.